Description of Event or Problem · 1
JOURNAL REFERENCE: WALLACE MS, RAUCK R, FISHER R, CHARAPATA SG, ELLIS D, DISSANAYAKE S. "INTRATHECAL ZICONOTIDE FOR SEVERE CHRONIC PAIN: SAFETY AND TOLERABILITY RESULTS OF AN OPEN-LABEL, LONG-TERM TRIAL." ANESTH ANALG 2008;106(2):628-637. THE PRIMARY OBJECTIVE OF THE CURRENT STUDY WAS TO INVESTIGATE THE SAFETY AND TOLERABILITY OF LONG-TERM ZICONOTIDE THERAPY USING A SLOW-TITRATION REGIMEN. THIS OPEN-LABEL, MULTICENTER, LONG-TERM, OUTPATIENT STUDY EVALUATED THE EFFICACY, SAFETY, AND TOLERABILITY OF IT ZICONOTIDE IN 644 PTS WITH SEVERE CHRONIC PAIN, WITH A PRIMARY FOCUS ON SAFETY AND TOLERABILITY. A TOTAL OF 744 INFUSION PUMPS WERE ASSOCIATED. SOME PTS HAD BOTH A MEDTRONIC IMPLANTABLE PUMP AND A CADDMICRO AMBULATORY INFUSION PUMP, SIMS DELTEC, INC. EVENT: ONE CASE OF MENINGITIS WAS REPORTED WITH AN IMPLANTED INFUSION SYSTEM.